Entries tagged "pharmaceutical mergers"
Back in August 2007, The Deal's Alex Lash outlined the reasons why Pfizer Inc. should shell out some major cash to purchase Wyeth. And now less than two years later -- voila! -- the two pharma giants are set to merge in a $68 billion deal. ...
Speculation about a Pfizer Inc. deal for Wyeth, first reported in Friday's Wall Street Journal, raises an age-old question that applies to more than just the pharmaceutical industry: size, its merits and demerits. Over the past decade or so, Pfizer has steadily built itself through acquisitions into a behemoth, and the Wyeth deal would push it to $75 billion in revenues. The argument for consolidation and great size has several parts, some obvious, some not. ...
Pharmaceutical company Eli Lilly and Co. made its biggest acquisition ever with its $6.5 billion cash deal to acquire biotech company ImClone Systems Inc. on Monday. But credit rating agency Fitch Ratings feels Eli Lilly is taking a risk that may warrant a possible credit rating downgrade....
